What are common complications that occur post solid organ transplantation?
What causes and how do you treat post-transplant hypertension?
Causes: Preexisting HTN, calcineurin inhibitors, corticosteroids
Management: Optimize blood pressure according to current JNC guidelines
What causes and how do you treat post-transplant diabetes mellitus?
The incidence is variable from 4-20% in the total transplant population
Causes: PTDM may be a direct side effect from the use of corticosteroids (enhanced glyconeogenesis) and to calcineurin inhibitors that may directed affect the release of insulin from beta cells.
Management: Glucose control according to the EBM guidelines
What causes and how do you treat post-transplant renal insufficiency?
can be seen in all transplant recipients, not just kidney. Close monitoring of renal function is key to avoid permanent renal injury and need for kidney transplantation
Causes: Etiology is most likely use of calcineurins but all co-morbidities must be assessed
Management: includes lowering dose of calcineurins (if possible), diabetes management, HTN management and avoidance of nephrotoxic drugs (NSAIDS, loop diuretics, certain antibiotics)
What causes and how do you treat post-transplant hyperlipidemia?
Cause: occurs in 50% or more of transplant recipients due to the effect of immunosuppressive medications on lipids
Management: Lipid levels should be optimized by current EBM guidelines
Hyperlipidemia Increases the risk of cardiovascular disease including nephropathy
What causes and how do you treat post-transplant bone disease?
Cause: Osteoporosis is a common complication after solid organ transplantation. It is directly related to corticosteroids with the maximum amount of bone loss occurring during the 3 months following surgery. Special attention should be given to tapering corticosteroids as allowed by protocol. Episodes of acute rejection requiring high dose steroid doses increase the incidence of bone disease.
Management: Baseline and annual bone scans. Corticosteroids should be minimized or discontinued according to transplant center protocol. Supplemental calcium, bisphosphonates and hormone replacements should be used if indicated.
What causes and how do you treat post-transplant malignancy?
Causes: there is an increased incidence of lymphoma, skin cancer and Kaposi’s sarcoma in the post- transplant population. Can also be associated with higher doses of cyclosporine and tacrolimus. Target levels should be used to dose these medications, toxic levels should be addressed.
Management:
What is the leading cause of death in solid organ transplant recipients?